Introduction In today’s era of precision medicine, scientists rely on highly specific tools to study diseases and design targeted treatments. Among the most valuable of these tools are custom monoclonal antibodies — laboratory-made molecules tailored to recognise unique proteins or antigens. From cancer immunotherapy to infectious disease diagnostics, these antibodies have become the backbone of